Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Achieve Life Sciences Inc’s stock clocked out at $3.04, up 2.36% from its previous closing price of $2.97. In other words, the price has increased by $2.36 from its previous closing price. On the day, 0.11 million shares were traded. ACHV stock price reached its highest trading level at $3.05 during the session, while it also had its lowest trading level at $2.89.
Ratios:
To gain a deeper understanding of ACHV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.51 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.97 whereas as Long-Term Debt/Eq ratio is at 0.85.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On September 27, 2024, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $20.
Maxim Group reiterated its Buy rating for the stock on May 10, 2023, while the target price for the stock was revised from $8 to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Oki Mark K bought 10,000 shares for $2.89 per share. The transaction valued at 28,887 led to the insider holds 10,000 shares of the business.
Stewart Richard Alistair bought 10,000 shares of ACHV for $28,598 on Mar 17 ’25. The Chieve Executive Officer now owns 60,876 shares after completing the transaction at $2.86 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 105442704 and an Enterprise Value of 92157616.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.55, which has changed by -0.43283582 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.59, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is 18.53%, while the 200-Day Moving Average is calculated to be -17.76%.
Shares Statistics:
It appears that ACHV traded 198.73K shares on average per day over the past three months and 262870 shares per day over the past ten days. A total of 34.69M shares are outstanding, with a floating share count of 29.37M. Insiders hold about 15.32% of the company’s shares, while institutions hold 45.35% stake in the company. Shares short for ACHV as of 1745971200 were 2526989 with a Short Ratio of 12.72, compared to 1743379200 on 2870159. Therefore, it implies a Short% of Shares Outstanding of 2526989 and a Short% of Float of 9.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
